Sandoz Executive and Leadership Team

Alexandre Jetzer, the President & Chief Executive Officer at Sandoz, directs the overarching strategy and global operations for the company. Jetzer architects the vision for Sandoz, ensuring the development, manufacturing, and delivery of high-quality generic medicines and biosimilars. This leadership role involves guiding Sandoz's market presence across critical therapeutic areas such as oncology, immunology, and cardiovascular health. By fostering innovation and operational excellence, Alexandre Jetzer drives Sandoz's mission to enhance patient access to essential treatments worldwide. The executive's focus remains on expanding the company's portfolio and solidifying its position as a leader in the global healthcare landscape, ensuring sustainable growth and continued impact on patient well-being.

Merab Babao, the Chief Financial Officer at Sandoz, oversees all financial operations and strategic financial planning for the organization. Babao manages global financial reporting, budgeting, and forecasting, ensuring fiscal discipline and driving profitability. This role is critical in supporting Sandoz's mission to provide accessible generic medicines and biosimilars by optimizing resource allocation and financial performance. Merab Babao works closely with other executive leaders to align financial strategies with the company's growth objectives and market expansion initiatives. The executive's responsibilities include managing investments, mitigating financial risks, and ensuring compliance with international financial regulations, thereby securing Sandoz's long-term financial health and operational stability across its global network.

Sam Kwok, the Chief Financial Officer (Asia) at Sandoz, directs financial strategy and operations across the Asian region. Kwok manages regional financial planning, analysis, and reporting, ensuring alignment with Sandoz's global financial objectives and local market dynamics. This leadership position is vital for expanding Sandoz's reach in providing generic medicines and biosimilars throughout Asia. Sam Kwok collaborates with regional business units to drive financial performance, optimize investments, and ensure regulatory compliance within diverse Asian markets. The executive's oversight includes managing capital allocation, enhancing profitability, and identifying growth opportunities to strengthen Sandoz's market position. Kwok's financial acumen supports the company's commitment to patient access in this key growth territory.

Sergio Santamaria, the Chief Financial Officer, Macc Region at Sandoz, leads financial management and strategic fiscal planning for the Macc region. Santamaria oversees regional financial reporting, budgeting, and treasury functions, ensuring robust financial controls and driving economic performance. This role is essential for Sandoz's objective of delivering high-quality generic medicines and biosimilars within the Macc territory. Sergio Santamaria partners with regional leadership to implement financial initiatives that support market penetration and operational efficiency. The executive's responsibilities encompass financial risk assessment, investment analysis, and ensuring adherence to all financial regulations pertinent to the Macc region. Santamaria's financial stewardship supports Sandoz's mission to improve healthcare access.

Martin Fournier, the Vice President, Finance & Chief Financial Officer at Sandoz, manages comprehensive financial operations and strategic financial direction. Fournier oversees global financial planning, accounting, and internal controls, ensuring fiscal integrity and driving sustainable growth. This critical position supports Sandoz's commitment to developing and delivering affordable generic medicines and biosimilars worldwide. Martin Fournier collaborates with executive teams to align financial strategies with corporate objectives, focusing on optimizing resource deployment and enhancing shareholder value. The executive's purview includes financial risk management, investment appraisal, and ensuring compliance with global financial standards. Fournier's leadership ensures Sandoz maintains a strong financial foundation to expand patient access to essential treatments.

Mohamed Hashem, the Chief Financial Officer, Gulf, Levant & Saudi at Sandoz, directs financial strategy and operations across the specified regions. Hashem manages regional financial planning, analysis, and reporting, ensuring fiscal health and supporting Sandoz's market expansion. This role is pivotal in delivering high-quality generic medicines and biosimilars to patients in the Gulf, Levant, and Saudi Arabia. Mohamed Hashem collaborates with local management to drive financial performance, optimize investments, and ensure strict adherence to regional financial regulations. The executive's responsibilities include financial risk mitigation, capital management, and identifying opportunities for revenue growth. Hashem's financial leadership reinforces Sandoz's commitment to improving healthcare accessibility in these key markets.

Monaz Noble, the Global Chief Financial Officer, Competency Centre & Country (India) at Sandoz, leads financial strategy for the global competency center and operations in India. Noble oversees financial planning, reporting, and performance management, ensuring fiscal efficiency and strategic alignment. This position is crucial for Sandoz's mission to provide affordable generic medicines and biosimilars, particularly supporting the Indian market and global competency functions. Monaz Noble works with cross-functional teams to optimize financial resources, manage budgets, and drive cost-effectiveness across operations. The executive's responsibilities include financial analysis, risk assessment, and ensuring compliance with both Indian and international financial standards. Noble's financial expertise strengthens Sandoz's operational capabilities and market presence.

Farit Temirgaliev, the Chief Financial Officer, Ca & Cau at Sandoz, manages financial operations and strategic fiscal planning for Canada and the Commonwealth of Independent States (Cau). Temirgaliev oversees regional financial reporting, budgeting, and treasury functions, ensuring robust financial controls and driving economic performance. This role is essential for Sandoz's objective of delivering high-quality generic medicines and biosimilars within these territories. Farit Temirgaliev partners with regional leadership to implement financial initiatives that support market penetration and operational efficiency. The executive's responsibilities encompass financial risk assessment, investment analysis, and ensuring adherence to all financial regulations pertinent to the Ca & Cau regions. Temirgaliev's financial stewardship supports Sandoz's mission to improve healthcare access.

Biakmawi Phaipi, the Team Captain at Sandoz, leads a dedicated team focused on specific operational objectives within the company. Phaipi directs team activities, ensuring efficient execution of assigned tasks and fostering a collaborative work environment. This role is integral to Sandoz's broader mission of delivering high-quality generic medicines and biosimilars by ensuring team productivity and adherence to project timelines. Biakmawi Phaipi works closely with management to align team efforts with departmental goals and company-wide strategies. The captain's responsibilities include motivating team members, resolving operational challenges, and contributing to the overall success of Sandoz's initiatives. Phaipi's leadership ensures the team effectively supports Sandoz's commitment to patient access.

Elena Morchenko, the Med at Sandoz, contributes expertise in medical affairs and related functions critical to the company's product development and market strategy. Morchenko supports the strategic delivery of Sandoz's high-quality generic medicines and biosimilars by providing essential medical insights. This role is vital in ensuring Sandoz's treatments meet rigorous medical standards and address patient needs across therapeutic areas like oncology and immunology. Elena Morchenko collaborates with research, development, and commercial teams to align medical strategies with business objectives. The individual's focus includes contributing to clinical understanding, supporting regulatory submissions, and ensuring the appropriate communication of medical information. Morchenko's medical knowledge enhances Sandoz's impact on global health.